Immunic(IMUX) - 2024 Q3 - Earnings Call Presentation

THERAPEU Immunic Therapeutics Developing Selective Oral Therapies in Immunology NASDAQ: IMUX | November 2024 Cautionary Note Regarding Forward-Looking Statements This presentation contains "forward-looking statements" that involve substantial risks and uncertainties for purposes of the safe harbor within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These include statements regarding management's intentions, plans, b ...